Epidemiological and bacterial profile of childhood meningitis in Tunisia

Acta Microbiol Immunol Hung. 2024 May 21;71(2):148-154. doi: 10.1556/030.2024.02208. Print 2024 Jul 2.

Abstract

The worldwide burden of disease of bacterial meningitis remains high, despite the decreasing incidence following introduction of routine vaccination campaigns.The aim of our study was to evaluate the epidemiological and bacteriological profile of paediatric bacterial meningitis (BM) in Tunisian children, during the period 2003-2019, following the implementation of Haemophilus influenzae type b (Hib) vaccine (April 2011) and before 10-valent pneumoccocal conjugate vaccine (PCV10) introduction to the childhood immunization program.All bacteriologically confirmed cases of BM admitted to children's hospital of Tunis were recorded (January 2003 to April 2019). Serogroups of Neisseria meningitidis (Nm) and serotypes of Streptococcus pneumoniae (Sp) and H. influenzae (Hi) and antibiotic resistance were determined using conventional and molecular methods.Among 388 cases, the most frequent species were Sp (51.3%), followed by Nm (27.5%) and Hi (16.8%). We observed a significant decrease in Hi BM rate during the conjugated Hib vaccine use period (P < 0.0001). The main pneumococcal serotypes were 14, 19F, 6B, 23F and 19A and the serotype coverage of PCV10, PCV13, PCV15 and PCV20 was 71.3 and 78.8%, 79.4 and 81.9% respectively. The most frequent Nm serogroup was B (83.1%). Most Hi strains were of serotype b (86.9%). High levels of resistance were found: Sp and Nm to penicillin (respectively 60.1 and 80%) and Hi to ampicillin (42.6%). All meningococcal and Hi isolates were susceptible to third-generation cephalosporins and 7.2% of pneumococcal strains had decreased susceptibility to these antibiotics.The Hib conjugate vaccine decreased the rate of BM. Sp dominated the aetiology of BM in children in Tunisia. Conjugate vaccines introducing decreases not only BM cases but also antimicrobial resistance.

Keywords: Tunisia; antimicrobial resistance; bacterial meningitis; children; vaccination.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents* / pharmacology
  • Bacterial Capsules
  • Child
  • Child, Preschool
  • Drug Resistance, Bacterial
  • Female
  • Haemophilus Vaccines / administration & dosage
  • Haemophilus influenzae / classification
  • Haemophilus influenzae / drug effects
  • Haemophilus influenzae / isolation & purification
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Meningitis, Bacterial* / epidemiology
  • Meningitis, Bacterial* / microbiology
  • Microbial Sensitivity Tests
  • Neisseria meningitidis* / classification
  • Neisseria meningitidis* / drug effects
  • Neisseria meningitidis* / isolation & purification
  • Pneumococcal Vaccines* / administration & dosage
  • Serogroup
  • Streptococcus pneumoniae* / classification
  • Streptococcus pneumoniae* / drug effects
  • Streptococcus pneumoniae* / isolation & purification
  • Tunisia / epidemiology

Substances

  • Pneumococcal Vaccines
  • Anti-Bacterial Agents
  • Haemophilus Vaccines
  • 10-valent pneumococcal conjugate vaccine
  • Haemophilus influenzae type b polysaccharide vaccine